PharmaBoardroom

Five of the key emerging trends in the booming global medical cannabis and cannabinoid medicine industries. Increasing Acceptance The…

Swedish biotech BioArctic, in collaboration with Japanese firm Eisai, has seen positive Phase IIb results for its BAN2401 antibody – potentially the…

Diabetes affects more than eight percent of the Thai population, a number that is on the rise, and nearly half of these cases remain undiagnosed. In…

In our latest Healthcare & Life Sciences Review, we look at Egypt. With a swathe of economic reforms in the pipeline, including the launch of the…

Dr Kumthorn Malathum, president of the Infectious Disease Association of Thailand, shares his insight on the issue of infectious disease in the…

Iddo Leshem, general manager Nordics at Bristol-Myers Squibb (BMS), talks about the uniqueness of Sweden’s collaborative culture and shatters some…

Karri Kivela, executive director of the European Association for Business and Commerce (EABC) in Thailand outlines the organization’s mains…

Dr Agustín Rullán, the newly appointed chancellor of the University of Puerto Rico Mayagüez (UPRM) and former dean of the university’s College of…

Dr Armin Wiesler, general manager and head of Human Pharma at Boehringer Ingelheim (Thai) Ltd., explores how the affiliate has managed to achieve…

Rocco De Bernardis, managing director for Johnson & Johnson Medical Devices in Spain offers his insights into the company’s local footprint,…

In a potentially significant step forward in biopharmaceutical supply chain logistics, a collaboration between AT&T, Direct Relief, MSD and…

Japan’s Opportunity to Establish a Blueprint for the World: Janssen Japan's Chris Hourigan makes the case for increased investment in, and access…